高通量无线侵入式脑机接口系统
Search documents
港股异动 脑机接口概念股集体高开 我国已完成三例侵入式脑机接口临床试验
Jin Rong Jie· 2025-12-18 02:01
智通财经获悉,脑机概念股集体高开,截至发稿,脑洞极光(06681)涨10.35%,报6.29港元;南京熊猫电 子股份(00553)涨1.63%,报4.36港元。 中信建投认为,脑机接口产业链上中游的技术进步带来下游应用端不断突破,近年来国内外在运动恢 复、语言沟通、听力重建等医疗领域的研究不断出现里程碑式成果。国家层面和各地区推出多项政策利 好行业加速发展,近期国家医保局发文为脑机接口新技术价格单独立项,其进入临床应用的服务收费路 径已经铺好。在技术革新和政策红利催化下,国内脑机接口公司有望逐步实现商业化应用。 本文源自:智通财经网 消息面上,据证券时报报道,中国科学院脑科学与智能技术卓越创新中心赵郑拓、李雪研究团队今年已 联合相关医院和企业,完成三例侵入式脑机接口临床试验,在生活场景应用方面实现突破。其中,在第 二例临床试验中,研究团队采用高通量无线侵入式脑机接口系统,使一位高位截瘫患者能够通过脑电信 号稳定操控智能轮椅与机器狗,在真实生活场景中实现自主移动与物品取用。 ...
脑机接口概念股集体高开 我国已完成三例侵入式脑机接口临床试验
Zhi Tong Cai Jing· 2025-12-18 01:36
脑机概念股集体高开,截至发稿,脑洞极光(06681)涨10.35%,报6.29港元;南京熊猫(600775)电子股 份(00553)涨1.63%,报4.36港元。 消息面上,据证券时报报道,中国科学院脑科学与智能技术卓越创新中心赵郑拓、李雪研究团队今年已 联合相关医院和企业,完成三例侵入式脑机接口临床试验,在生活场景应用方面实现突破。其中,在第 二例临床试验中,研究团队采用高通量无线侵入式脑机接口系统,使一位高位截瘫患者能够通过脑电信 号稳定操控智能轮椅与机器狗,在真实生活场景中实现自主移动与物品取用。 中信建投(601066)认为,脑机接口产业链上中游的技术进步带来下游应用端不断突破,近年来国内外 在运动恢复、语言沟通、听力重建等医疗领域的研究不断出现里程碑式成果。国家层面和各地区推出多 项政策利好行业加速发展,近期国家医保局发文为脑机接口新技术价格单独立项,其进入临床应用的服 务收费路径已经铺好。在技术革新和政策红利催化下,国内脑机接口公司有望逐步实现商业化应用。 ...
港股异动 | 脑机接口概念股集体高开 我国已完成三例侵入式脑机接口临床试验
智通财经网· 2025-12-18 01:34
智通财经APP获悉,脑机概念股集体高开,截至发稿,脑洞极光(06681)涨10.35%,报6.29港元;南京熊 猫电子股份(00553)涨1.63%,报4.36港元。 消息面上,据证券时报报道,中国科学院脑科学与智能技术卓越创新中心赵郑拓、李雪研究团队今年已 联合相关医院和企业,完成三例侵入式脑机接口临床试验,在生活场景应用方面实现突破。其中,在第 二例临床试验中,研究团队采用高通量无线侵入式脑机接口系统,使一位高位截瘫患者能够通过脑电信 号稳定操控智能轮椅与机器狗,在真实生活场景中实现自主移动与物品取用。 中信建投认为,脑机接口产业链上中游的技术进步带来下游应用端不断突破,近年来国内外在运动恢 复、语言沟通、听力重建等医疗领域的研究不断出现里程碑式成果。国家层面和各地区推出多项政策利 好行业加速发展,近期国家医保局发文为脑机接口新技术价格单独立项,其进入临床应用的服务收费路 径已经铺好。在技术革新和政策红利催化下,国内脑机接口公司有望逐步实现商业化应用。 ...
我国已完成三例侵入式脑机接口临床试验 在生活场景应用方面实现新突破
Zheng Quan Shi Bao Wang· 2025-12-17 03:03
人民财讯12月17日电,12月17日,证券时报记者从中国科学院脑科学与智能技术卓越创新中心获悉,该 中心赵郑拓、李雪研究团队今年已联合相关医院和企业,完成三例侵入式脑机接口临床试验,在生活场 景应用方面实现突破。其中,在第二例临床试验中,研究团队采用高通量无线侵入式脑机接口系统,使 一位高位截瘫患者能够通过脑电信号稳定操控智能轮椅与机器狗,在真实生活场景中实现自主移动与物 品取用。 ...
科技“绝活”剧透未来 上交会助力建设创新高地
Zhong Guo Zheng Quan Bao· 2025-06-12 20:48
Group 1: Event Overview - The 11th China (Shanghai) International Technology Import and Export Fair was held from June 11 to June 13, focusing on "hard technology" and future industries, showcasing nearly a hundred breakthrough achievements in fields like brain-machine interfaces, embodied intelligence, quantum technology, and synthetic biology [1][2] - The event highlighted significant innovations such as the world's first sound tweezers single-cell sorting technology and the debut of self-developed lunar soil fiber technology and equipment, indicating a promising future for the technology industry [1][2] Group 2: Innovations in Lunar Technology - East China University of Science and Technology showcased the "in-situ preparation of lunar soil fiber modular equipment," which is included in China's lunar base construction plan, utilizing lunar soil from the Chang'e 5 mission to create fibers for lunar base construction [2] - The technology aims to convert lunar soil into high-performance fibers, enabling local resource utilization and meeting the material performance needs for lunar base construction [2] Group 3: Advancements in Biotechnology - The Soundpen CB system developed by Oubino Biotechnology employs non-contact, label-free acoustic tweezers to manipulate cells with precision, significantly enhancing experimental efficiency by minimizing cell damage [3] - The event also featured brain-machine interface technologies that allow patients with central nervous system injuries to control exoskeletons for rehabilitation, demonstrating practical applications in hospitals and rehabilitation centers [5][6] Group 4: Robotics and Automation - The fair showcased various robots, including a six-legged robot designed for Antarctic research, which can assist in transporting materials and ensuring safety by detecting cracks in the ice [3][4] - Nanjing University presented a multimodal interactive robot capable of intelligent dialogue and music synchronization, which is already in mass production and available in North America [4] Group 5: 3D Printing in Pharmaceuticals - The company San Diego demonstrated its 3D printing technology for pharmaceuticals, achieving continuous and large-scale production of printed drugs, with an annual capacity of 75 million to 300 million tablets [6] - Lepu Medical introduced the MemoSorb biodegradable occluder series, the first of its kind globally, providing innovative treatment solutions for congenital heart disease and stroke prevention [6]